We are live on ! Find out more
RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

66 hedge funds and large institutions have $41.1M invested in RVL Pharmaceuticals plc Ordinary Shares in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 16

61% more capital invested

Capital invested by funds: $25.6M → $41.1M (+$15.5M)

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

6% more funds holding

Funds holding: 62 → 66 (+4)

Holders
66
Holders Change
+4
Holders Change %
+6.45%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
26
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DCM
DG Capital Management
New York
+$3.91M
2
BlackRock
BlackRock
New York
+$1.28M
3
GC
Globeflex Capital
California
+$481K
4
EP
Eversept Partners
New York
+$387K
5
JIC
Joel Isaacson & Co
New York
+$220K

Top Sellers

Rank Fund Capital Flow
1
SS
Sunbelt Securities
Texas
-$5.03M
2
SCM
Sio Capital Management
New York
-$1.83M
3
Millennium Management
Millennium Management
New York
-$1.33M
4
WCM
Wedge Capital Management
North Carolina
-$898K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$852K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
51
Barclays
United Kingdom
$46K +$18.4K +3,753 +127%
Deutsche Bank
52
Deutsche Bank
Germany
$37K +$14.8K +3,023 +121%
Citigroup
53
Citigroup
New York
$35K -$5.03K -1,027 -16%
RA
54
Royce & Associates
New York
$34K -$5.74K -1,172 -19%
TRCT
55
Tower Research Capital (TRC)
New York
$33K +$23.2K +4,746 +2,187%
Daiwa Securities Group
56
Daiwa Securities Group
Japan
$32K – – –
JP Morgan Chase
57
JP Morgan Chase
New York
$27K +$7.32K +1,496 +59%
PHK
58
Point72 Hong Kong
Hong Kong
$23K -$2.92K -596 -15%
SO
59
STRS Ohio
Ohio
$17K – – –
Legal & General Group
60
Legal & General Group
United Kingdom
$11K +$1.55K +316 +23%
OSAM
61
O'Shaughnessy Asset Management
Connecticut
$9K +$6.36K +1,299 New
Bank of Montreal
62
Bank of Montreal
Ontario, Canada
$7K +$2.52K +516 +118%
AIP
63
Ameritas Investment Partners
Nebraska
$5K – – –
BNP Paribas Financial Markets
64
BNP Paribas Financial Markets
France
$2.78K -$11K -2,252 -85%
Federated Hermes
65
Federated Hermes
Pennsylvania
$2K -$1.61K -330 -60%
SSB
66
Sandy Spring Bank
Maryland
$1K +$489 +100 New
SCM
67
Sio Capital Management
New York
– -$1.83M -575,000 Closed
Millennium Management
68
Millennium Management
New York
– -$1.33M -418,646 Closed
Squarepoint
69
Squarepoint
New York
– -$551K -173,385 Closed
MF
70
Magnetar Financial
Illinois
– -$114K -35,786 Closed
SIM
71
Spark Investment Management
New York
– -$88K -27,710 Closed
COPPSERS
72
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$54K -16,950 Closed
Two Sigma Investments
73
Two Sigma Investments
New York
– -$52K -16,200 Closed
State of Tennessee, Department of Treasury
74
State of Tennessee, Department of Treasury
Tennessee
– -$32K -10,149 Closed
PPA
75
Parametric Portfolio Associates
Washington
– -$32K -10,091 Closed
1 2
3
4

RVLP Hedge Fund Activity: Q2 2020 in Review

66 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q2 2020, worth a combined $41.1M — up 61% from $25.6M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RVLP positions and 10 closed out — a net gain of 5 holders — while 26 added to existing stakes and 16 trimmed.

The largest buyer was DG Capital Management, opening a new position worth an estimated $3.91M. The largest seller was Sunbelt Securities, cutting an estimated $5.03M.

  • 66 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q2 2020, up from 62 in Q1 2020.
  • Funds reported $41.1M of RVL Pharmaceuticals plc Ordinary Shares stock for Q2 2020, up 61% quarter-over-quarter.
  • 15 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q2 2020 and 10 closed out, a net change of +5 holders.
  • The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q2 2020 was DG Capital Management, an estimated $3.91M added.
  • The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q2 2020 was Sunbelt Securities, an estimated $5.03M sold.

Based on aggregated 13F filings for Q2 2020.